LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 45.61 | 770.25 | 5170 | 5813 | 0.8894 | 0.9212 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.83 | 770.25 | 4319 | 6223 | 0.6940 | 0.7717 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.83 | 770.25 | 5600 | 6223 | 0.8998 | 0.9312 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 50.05 | 770.25 | 4716 | 6629 | 0.7114 | 0.7923 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 50.05 | 770.25 | 5920 | 6629 | 0.8930 | 0.9284 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 52.27 | 770.25 | 5025 | 7058 | 0.7119 | 0.7982 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 52.27 | 770.25 | 6404 | 7058 | 0.9072 | 0.9400 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 54.49 | 770.25 | 5403 | 7555 | 0.7151 | 0.8064 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 54.49 | 770.25 | 6778 | 7555 | 0.8971 | 0.9351 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 56.71 | 770.25 | 5759 | 8001 | 0.7197 | 0.8144 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 56.71 | 770.25 | 7395 | 8001 | 0.9242 | 0.9539 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.94 | 770.25 | 6220 | 8444 | 0.7366 | 0.8306 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.94 | 770.25 | 7764 | 8444 | 0.9194 | 0.9520 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 61.16 | 770.25 | 6497 | 8892 | 0.7307 | 0.8298 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 61.16 | 770.25 | 8226 | 8892 | 0.9251 | 0.9564 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.39 | 770.25 | 6930 | 9326 | 0.7431 | 0.8416 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.39 | 770.25 | 8755 | 9326 | 0.9388 | 0.9652 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 65.61 | 770.25 | 7225 | 9736 | 0.7421 | 0.8435 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 65.61 | 770.25 | 9098 | 9736 | 0.9345 | 0.9633 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.83 | 770.25 | 7662 | 10078 | 0.7602 | 0.8576 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.83 | 770.25 | 9389 | 10078 | 0.9316 | 0.9622 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.05 | 770.25 | 8116 | 10413 | 0.7794 | 0.8716 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.05 | 770.25 | 9806 | 10413 | 0.9417 | 0.9683 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 72.27 | 770.25 | 8342 | 10730 | 0.7774 | 0.8718 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 72.27 | 770.25 | 10293 | 10730 | 0.9592 | 0.9782 | MN20160304_L02 | I20 |